Kenneth Foon

Affiliations

Celegene Corporation, Summit, NJ.

Publications (1)

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.

Blood

Avec: Carla Casulo , Jesse G Dixon , Jennifer Le-Rademacher , Eva Hoster , Howard S Hochster , Wolfgang Hiddemann , Robert Marcus , Eva Kimby , Michael Herold , Catherine Sebban , Emmanuel Gyan , Kenneth Foon , Tina Nielsen , Umberto Vitolo , Gilles A Salles , Qian Shi , Christopher R Flowers

Réseau de co-auteurs

Carla Casulo 1 collaboration

Jesse G Dixon 1 collaboration

Jennifer Le-Rademacher 1 collaboration

Eva Hoster 1 collaboration

Howard S Hochster 1 collaboration

Wolfgang Hiddemann 1 collaboration

Robert Marcus 1 collaboration

Eva Kimby 1 collaboration

Michael Herold 1 collaboration

Catherine Sebban 1 collaboration

Emmanuel Gyan 1 collaboration

Tina Nielsen 1 collaboration

Umberto Vitolo 1 collaboration

Gilles A Salles 1 collaboration

Qian Shi 1 collaboration

Christopher R Flowers 1 collaboration